TickPlex – First Immunoassay for persister forms

(Temporarily unavailable to U.S. residents since March 2020)

The TickPlex assay is performed on the basis of an ELISA. However, compared to other ELISA assays, this test contains a new antigen for round bodies/persister forms of Borrelia.
TickPlex is an accredited test and can be used at different stages of the disease.
TickPlex Plus allows the simultaneous determination of IgM and IgG antibodies of several bacterial and viral pathogens.
With its high sensitivity of approx. 95% and a specificity of 98%, TickPlex is superior to comparable IFA test methods that have been used so far.


These Downloads provide more information on the certification of the Tickplex tests:

Tezted ISO 13485 Certificate
Tickplex Validation Process
EU declaration of conformity for Tickplex Plus

The published Nature Paper underlines the relevance of polymicrobial infection testing
  • Tickplex Basic IgG/IgM tests for

Borrelia burgdorferi

  • Tickplex Plus IgG/IgM tests for

Borrelia burgdorferi
Ehrlichia
Bartonella
Babesia
Mycoplasma
Rickettsia
Epstein Barr Virus (EBV)
Coxsackie-Virus
Parvovirus